Global Platelet-Rich Plasma Market Size To Worth USD 2921.2 Million By 2033 | CAGR Of 14.99%
Category: HealthcareGlobal Platelet-Rich Plasma Market Size To Worth USD 2921.2 Million By 2033 | CAGR Of 14.99%
According to a research report published by Spherical Insights & Consulting, the Global Platelet-Rich Plasma Market Size is Expected to Grow from USD 722.7 million in 2023 to USD 2921.2 million by 2033, at a CAGR of 14.99% during the forecast period 2023-2033.
Get more details on this report -
Browse key industry insights spread across 219 pages with 120 Market data tables and figures & charts from the report on the "Global Platelet-Rich Plasma Market Size, Share, and COVID-19 Impact Analysis, By Product (Platelet-Rich Fibrin (PRF), Leukocyte-Rich Platelet-Rich Plasma (L-PRP), Pure Platelet-Rich Plasma (Pure PRP), and Others), By Application (Neurology, Orthopedics, Wound Care, Cosmetics, and Others), By End-User (Clinics, Hospitals, and Others), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033." Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/platelet-rich-plasma-market
The platelet-rich plasma (PRP) market involves the production, distribution, and clinical application of PRP, a concentrated plasma enriched with platelets, growth factors, and bioactive proteins. PRP is used in cosmetic surgery to improve skin appearance and overall health and has shown positive results in facial rejuvenation. PRP injections accelerate the healing of damaged tendons, ligaments, muscles, bones, and joints, reducing the need for opioids and anti-inflammatory medications. PRP works by activating growth factors and increasing reparative cells, enhancing the body's natural healing process. Government initiatives and regulatory guidelines are essential for the growth of the PRP market. The USFDA and CBER regulate human cell, tissue, PRP, and product research, while the 510(k) application allows products to be "substantially equivalent" to existing ones. Platelet-rich plasma (PRP) is a popular treatment in cosmetic surgery and dermatology for skin rejuvenation and healing. PRP injections are used for tendon, muscle, and ligament injuries, orthopedic diseases, musculoskeletal ailments, and sports injuries. The market is expected to grow due to its increasing applications in plastic surgery, fat grafting, laser therapy, acne scar removal, and skin rejuvenation. However, the high cost of PRP products may impede the market growth.
The pure platelet-rich plasma (pure PRP) segment held the largest share of 46.72% in 2023 and is predicted to grow at a significant CAGR during the predicted period.
Based on the product, the global platelet-rich plasma market is categorized as platelet-rich fibrin (PRF), leukocyte-rich platelet-rich plasma (L-PRP), pure platelet-rich plasma (pure PRP), and others. Among these, the pure platelet-rich plasma (pure PRP) segment held the largest share of 46.72% in 2023 and is predicted to grow at a significant CAGR during the predicted period. The growth of this segment is driven by its safety, skin tissue regeneration, tolerability, minimal side effects, increased off-label use, wound healing, pain relief, chronic injuries, and growing dermatologic diseases like alopecia and vitiligo.
The orthopedics segment accounted for the highest market share of 23.68% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the application, the global platelet-rich plasma market is categorized as neurology, orthopedics, wound care, cosmetics, and others. Among these, the orthopedics segment accounted for the highest market share of 23.68% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The segment's growth is attributed to PRP's effectiveness in musculoskeletal injuries, its regeneration and healing properties, its widespread use in knee osteoarthritis and muscle strains, enhanced healing post-reconstruction, and the increasing demand for non-invasive orthopedic procedures.
The hospitals segment accounted for the highest market share of 23.68% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.
Based on the end-user, the global platelet-rich plasma market is categorized as clinics, hospitals, and others. Among these, the hospitals segment accounted for the highest market share of 23.68% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The segment's growth is attributed to PRP's effectiveness in musculoskeletal injuries, its regeneration and healing properties, its widespread use in knee osteoarthritis and muscle strains, enhanced healing post-reconstruction, and its increasing demand for non-invasive orthopedic procedures.
North America is expected to hold the greatest share of the global platelet-rich plasma market over the forecast period.
Get more details on this report -
North America is expected to hold the greatest share of the global platelet-rich plasma market over the forecast period. North America's healthcare system, high musculoskeletal illnesses, and emphasis on medical technology make it a dominant player in the platelet-rich plasma (PRP) market. The region's recognition of cosmetic operations and favorable reimbursement conditions further strengthen its position. The region's numerous production facilities, high end-user procurement rates, and regulatory backing are expected to drive growth and market expansion.
Asia Pacific is predicted to hold the fastest-growing region of the global platelet-rich plasma market throughout the estimated period. The growing demand for platelet-rich plasma (PRP) treatment in Asia due to the increasing prevalence of orthopedic, neurological, cardiovascular, sports injuries, and obesity is driving the growth of the market. This treatment is safe and cost-efficient, as platelets are injected into the injured site. The market is also expected to benefit from increased awareness in emerging nations like India and China.
Major key players in the global platelet-rich plasma market are Terumo Corporation, Zimmer Biomet, Celling Biosciences, Inc., Juventix Regenerative Medical, LLC., Emcyte Corporation, Johnson & Johnson Services, Inc., APEX Biologix, Regen Lab SA, Harvest Technology, Biolife Plasma Services, Cambryn Biologics LLC., Octapharma, and others.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Recent Development
- In February 2025, VetStem, Inc., a pioneer in regenerative veterinary medicine, entered into an Exclusive License and Supply Agreement with PetVivo Holdings, Inc. to commercialize its innovative allogeneic orthobiologic products, PrecisePRP™ Canine and PrecisePRP™ Equine. PrecisePRP™ is a groundbreaking, off-the-shelf platelet-rich plasma (PRP) product designed for ease of use by veterinarians. This first-in-class, leucoreduced, allogeneic, pooled, and freeze-dried PRP provides a species-specific source of concentrated platelets in plasma for intra-articular administration in dogs and horses.
Market Segment
This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global platelet-rich plasma market based on the below-mentioned segments:
Global Platelet-Rich Plasma Market, By Product
- Platelet-Rich Fibrin (PRF)
- Leukocyte-Rich Platelet-Rich Plasma (L-PRP)
- Pure Platelet-Rich Plasma (Pure PRP)
- Others
Global Platelet-Rich Plasma Market, By Application
- Neurology
- Orthopedics
- Wound Care
- Cosmetics
- Others
Global Platelet-Rich Plasma Market, By End-User
- Clinics
- Hospitals
- Others
Global Platelet-Rich Plasma Market, By Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?